Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.

Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop

Open access

Abstract

The National Heart, Lung, and Blood Institute (NHLBI) convened a workshop of international experts to discuss new research opportunities for the prevention, detection, and intervention of myocarditis in May 2021. These experts reviewed the current state of science and identified key gaps and opportunities in basic, diagnostic, translational, and therapeutic frontiers to guide future research in myocarditis. In addition to addressing community-acquired myocarditis, the workshop also focused on emerging causes of myocarditis including immune checkpoint inhibitors and SARS-CoV-2 related myocardial injuries and considered the use of systems biology and artificial intelligence methodologies to define workflows to identify novel mechanisms of disease and new therapeutic targets. A new priority is the investigation of the relationship between social determinants of health (SDoH), including race and economic status, and inflammatory response and outcomes in myocarditis. The result is a proposal for the reclassification of myocarditis that integrates the latest knowledge of immunological pathogenesis to refine estimates of prognosis and target pathway-specific treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm11195721

Cites

120 of 121 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 T helper cell pathways leading to three subtypes of myocarditis. Viral myocarditis activating Th1 pathway driven by IL-12 induces IFNγ production and CD8+ T cells as the main effector cells. Hypersensitivity myocarditis is induced by Th2 pathway driven by cytokines (IL-4, IL5, and IL13), mast cells, eosinophils, and B cells. Autoimmune myocarditis is driven by the Th17 pathway, with the IL17A/ F, and GM-CSF as the main cytokines inducing neutrophil and inflammatory monocyte responses.
Figure 1 T helper cell pathways leading to three subtypes of myocarditis. Viral myocarditis activating Th1 pathway driven by IL-12 induces IFNγ production and CD8+ T cells as the main effector cells. Hypersensitivity myocarditis is induced by Th2 pathway driven by cytokines (IL-4, IL5, and IL13), mast cells, eosinophils, and B cells. Autoimmune myocarditis is driven by the Th17 pathway, with the IL17A/ F, and GM-CSF as the main cytokines inducing neutrophil and inflammatory monocyte responses.CC BY · PubMed Central
Figure 2 Experimental autoimmune myocarditis murine model. In the EAM model, cardiac myosin or the relevant peptide in Freund’s complete adjuvant is injected subcutaneously into mice on day 0 and day 7. The immune response, the histological changes, and the genetic susceptibility observed in EAM are similar to giant cell myocarditis. #: The numbers are identifying the epitope of myosin heavy chain (MYHC) used for the induction of myocarditis.
Figure 2 Experimental autoimmune myocarditis murine model. In the EAM model, cardiac myosin or the relevant peptide in Freund’s complete adjuvant is injected subcutaneously into mice on day 0 and day 7. The immune response, the histological changes, and the genetic susceptibility observed in EAM are similar to giant cell myocarditis. #: The numbers are identifying the epitope of myosin heavy chain (MYHC) used for the induction of myocarditis.CC BY · PubMed Central
Figure 3 Immune regulation of coxsackievirus B3-induced myocarditis. Coxsackievirus B3 has the ability to infect cardiomyocytes. The innate immune system including ILCs, NK cells, macrophages, and dendritic cells in the heart is activated after the release of damage-associated molecular patterns (DAMPs). Cardiac stroma cells such as fibroblasts are also activated. Together with the immune cells, they release chemokines and cytokines that attract other immune cells from circulation. In addition, bone marrow is activated and increases hematopoiesis by the heart-derived mediators such as IL-1β, GM-CSF, and DAMPs. The gut is a possible other source of inflammatory cells such as Th17 cells that could have been primed by gut microbiota.
Figure 3 Immune regulation of coxsackievirus B3-induced myocarditis. Coxsackievirus B3 has the ability to infect cardiomyocytes. The innate immune system including ILCs, NK cells, macrophages, and dendritic cells in the heart is activated after the release of damage-associated molecular patterns (DAMPs). Cardiac stroma cells such as fibroblasts are also activated. Together with the immune cells, they release chemokines and cytokines that attract other immune cells from circulation. In addition, bone marrow is activated and increases hematopoiesis by the heart-derived mediators such as IL-1β, GM-CSF, and DAMPs. The gut is a possible other source of inflammatory cells such as Th17 cells that could have been primed by gut microbiota.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 121 references

Research works printed but not linked: 2

  1. National Heart, L. (2022, January 06). Blood Institute (NHLBI). Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention Workshop- Executive Summary, Available online: https://www.nhlbi.nih.gov/events/2021/meeting-challenges-myocarditis-workshop.
  2. Grant, 1993, Recurrent giant cell myocarditis after transplantation, J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant., 12, 155

Cited by

See all 13

Metadata

Authors
Čiháková, D., Shi, Y., Adhikari, B., Bandettini, W. P., Cunningham, M. W., Danthi, N., Friedrich, M. G., Liu, P., Longacre, L. S., Mann, D. L., Swirski, F. K., Tang, W. H. W., Zhou, G., & Cooper, Jr.
Affiliations
  • Johns Hopkins University (US)
  • National Institutes of Health (US)
  • University of Oklahoma Health Sciences Center (US)
  • McGill University Health Centre (CA)
  • University of Ottawa (CA)
  • Washington University in St. Louis (US)
  • Cardiovascular Research Institute and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
  • Cleveland Clinic (US)
  • Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL 32224, USA
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2022-09-27
Volume
11
Issue
19
Pages
5721
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4297538840
Cited by
13
References
121
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 2
FWCI
1.74
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Heart, Lung, and Blood Institute (R35HL135752)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
Keywords
myocarditis, immune checkpoint inhibitors, immune pathogenesis, social determinants of health, systems biology, artificial intelligence, therapeutic target, prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop. https://app.cochat.ai/papers/10.3390/jcm11195721
The paper
Čiháková, D., Shi, Y., Adhikari, B., Bandettini, W. P., Cunningham, M. W., Danthi, N., Friedrich, M. G., Liu, P., Longacre, L. S., Mann, D. L., Swirski, F. K., Tang, W. H. W., Zhou, G., & Cooper, Jr. (2022). Meeting the Challenges of Myocarditis: New Opportunities for Prevention, Detection, and Intervention—A Report from the 2021 National Heart, Lung, and Blood Institute Workshop. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11195721

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.